About: Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries
Creator	Carvalho, Jesus Colombo Bonadio, Renata Del Pilar Estevez-Diz, Maria Miranda, Vanessa
source	Medline; PMC; WHO
abstract	During the COVID-19 pandemic, health services worldwide are going through important adaptations to assist patients infected with COVID-19, at the same time as continuing to provide assistance to other potentially life-threatening diseases. Although patients with cancer may be at increased risk for severe events related to COVID-19 infection, their oncologic treatments frequently cannot be delayed for long periods without jeopardising oncologic outcomes. Considering this, a careful consideration for treatment management of different malignancies is required. Cervical cancer is concentrated mainly in low-middle income countries (LMICs), which face particular challenges during the COVID-19 pandemic due to the scarcity of health resources in many places. Although cervical cancer is the fourth cause of cancer death among women, it receives little attention from international Oncology societies and scientific research studies. In this review paper, we discuss the cervical cancer landscape and provide specialists recommendations for its management during the COVID-19 pandemic, particularly focused on LMICs’ reality.
has issue date	2020-06-17(xsd:dateTime)
bibo:doi	10.3332/ecancer.2020.1060
bibo:pmid	32582375
has license	cc-by
sha1sum (hex)	0ac450a22e8f1e371aae7bc7a01d41a1cd0a9f64
schema:url	https://doi.org/10.3332/ecancer.2020.1060
resource representing a document's title	Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries
has PubMed Central identifier	PMC7302891
has PubMed identifier	32582375
schema:publication	Ecancermedicalscience
resource representing a document's body	covid:0ac450a22e8f1e371aae7bc7a01d41a1cd0a9f64#body_text
is schema:about of	named entity 'risk' named entity 'WORLDWIDE' named entity 'TO PROVIDE' covid:arg/0ac450a22e8f1e371aae7bc7a01d41a1cd0a9f64 named entity 'patients' named entity 'infected' named entity 'life-threatening diseases' named entity 'randomised trial' named entity 'COVID' named entity 'Europe' named entity 'oncology' named entity 'cervical cancer' named entity 'statistically significant' named entity 'first-line' named entity 'COVID-19 pandemic' named entity 'COVID-19 pandemic' named entity 'infection' named entity 'cervical cancer' named entity 'cervical cancer' named entity 'COVID-19 virus' named entity 'COVID' named entity 'malignancy' named entity 'immunosuppressive' named entity 'United States of America' named entity 'COVID-19' named entity 'radiation therapy' named entity 'working conditions' named entity 'health care' named entity 'cervical cancer' named entity 'infection' named entity 'chronic diseases' named entity 'high-risk groups' named entity 'early-stage' named entity 'surgical procedure' named entity 'COVID-19 pandemic' named entity 'COVID' named entity 'Systemic therapy' named entity 'health care' named entity 'cervical cancer' named entity 'upper respiratory' named entity 'COVID' named entity 'COVID-19 pandemic' named entity 'COVID' named entity 'COVID' named entity 'demand for health' named entity 'cervical cancer' named entity 'infection' named entity 'Cervical cancer' named entity 'cervical cancer' named entity 'radiation therapy' named entity 'reverse transcription-polymerase chain reaction' named entity 'cervical cancer' named entity 'intraepithelial neoplasia' named entity 'outpatient setting' named entity 'surgical treatment' named entity 'COVID' named entity 'infection' named entity 'doi' named entity 'oncologic' named entity 'cancer care' named entity 'health services' named entity 'health services' named entity 'health systems' named entity 'bevacizumab' named entity 'health services' named entity 'malignancies' named entity 'premalignant lesions' named entity 'RT-PCR' named entity 'asymptomatic patients' named entity 'LMIC' named entity 'COVID-19 tests' named entity 'systemic therapy' named entity 'phase II study' named entity 'telemedicine' named entity 'COVID-19 infection' named entity 'Pap smear' named entity 'metastatic' named entity 'first-line'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software